NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials.

Forlano, Roberta; Mullish, Benjamin H; Maurice, James B; Thursz, Mark R; Goldin, Robert D; Manousou, Pinelopi

Forlano, Roberta; Mullish, Benjamin H; Maurice, James B; Thursz, Mark R; Goldin, Robert D; Manousou, Pinelopi.

Afiliação

Forlano R; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
Mullish BH; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
Maurice JB; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
Thursz MR; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
Goldin RD; Centre for Pathology, Department of Medicine, Imperial College, London, UK.
Manousou P; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK. Electronic address: p.manousou@imperial.ac.uk.

J Hepatol ; 74(1): 241-242, 2021 01.

Article em En | MEDLINE | ID: mdl-33012546

Assuntos

Hepatopatia Gordurosa não Alcoólica; Biópsia; Humanos; Fígado

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Limite: Humans Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google